NKTX
USDNkarta Inc. Common Stock
$1.970-0.040 (-1.990%)
Real-time Price
Healthcare
Biotechnology
United States
Price Chart
Loading Chart...
Key Metrics
Market Metrics
Open
$2.010
High
$2.055
Low
$1.960
Volume
0.61M
Company Fundamentals
Market Cap
139.9M
Industry
Biotechnology
Country
United States
Trading Stats
Avg Volume
0.86M
Exchange
NMS
Currency
USD
52-Week Range
Low $1.31Current $1.970High $3.81
Related News
GlobeNewswire
Nkarta to Participate in November Investor Conferences
SOUTH SAN FRANCISCO, Calif., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Nkarta, Inc. (NASDAQ:NKTX), a clinical-stage biopharmaceutical company developing engineered natural killer (NK) cell therapies, today announced its
View more
GlobeNewswire
Nkarta Announces Poster Presentation at Upcoming American College of Rheumatology (ACR) Convergence Meeting
SOUTH SAN FRANCISCO, Calif., Oct. 22, 2025 (GLOBE NEWSWIRE) -- Nkarta, Inc. (NASDAQ:NKTX), a clinical-stage biopharmaceutical company developing engineered natural killer (NK) cell therapies to treat autoimmune
View more
Related Stocks
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.